N/A
N=6
Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
Catecholaminergic Polymorphic Ventricular Tachycardia
Bottom Line
View on ClinicalTrials.gov: NCT02927223 ↗Enrolled (actual)
6
Serious AEs
0.0%
Results posted
Jan 2020
Primary outcome: Primary: Number of Ventricular Ectopic Beats Recorded During Exercise (and Recovery) — 46; 0 number of ventricular beats
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Atropine (Drug); Exercise treadmill test (Procedure)
- Age
- Pediatric, Adult, Older Adult · 6+ yrs
- Sex
- All
- Sponsor
- Vanderbilt University
- Primary completion
- Feb 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Ventricular Ectopic Beats Recorded During Exercise (and Recovery) |
46; 0 | — |
Summary
To test the hypothesis that increasing the sinus node rate with atropine treatment prior to exercise will reduce exercise-triggered ventricular ectopy compared to baseline in patients with CPVT.
Eligibility Criteria
Inclusion Criteria
- Age >/= 6 years
- Able to provide written informed consent
- Clinical diagnosis of CPVT
- Able to exercise on a treadmill
- Successful completion of a minimum of 2 exercise stress tests without adverse events
Exclusion Criteria
- Contraindication to treadmill stress testing according to Vanderbilt University Medical Center's clinical protocols (unstable angina, decompensated congestive heart failure, severe hypertension (≥ 170/90 mmHg), acute myocardial infarction (<4 days), moderate to severe aortic stenosis, acute pulmonary embolism, severe pulmonary hypertension, outflow tract obstruction, hypertrophic cardiomyopathy, left main coronary stenosis, left bundle branch block)
- Females who are pregnant
- In the judgement of the investigator, any clinically significant ongoing medical or surgical condition that might jeopardize the subject's safety or interfere with the conduct of the study
Data sourced from ClinicalTrials.gov (NCT02927223). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.